Unlock the full webinar with a free trial: https://fsinsight.com/full-services/?utm_medium=social&utm_source=youtube&utm_campaign=replay-jan-macro-update
1 extracted signal · 1 resolved · 0 still active
Fundstrat14 Jan 2026, 03:15 UTC
AI-generated source summary
Apple (AAPL) has experienced a recent sell-off, losing approximately 10% since December. Despite this, the stock appears to be finding support around the 260.00 level, which corresponds to prior resistance and Fibonacci retracement levels from the August 2023 low. The Ichimoku cloud on a daily timeframe suggests this area could act as a significant support zone. Given the stock's ability to hold this level and show some recovery towards the end of the trading week, a bullish outlook is proposed. The target price is set at 275.00, with an invalidation level below the recent lows, specifically at 250.00, which would signal a failure of this bullish setup and indicate a more significant downtrend. The current price is 260.14.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Signals in this source
More Prediction Case Files from Fundstrat
Tom Lee: Why Crypto Is Rising While Semis Fall
Is the Chip Selloff a Buying Opportunity?
Fundstrat: What to make of elevated dispersion?
Is a 10% to 15% Market Pullback Coming?
Tom Lee: The Market Misread the Fed
Fundstrat: Stocks Are at Record Highs. Crypto Isn't.
Fundstrat
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.